F15.25
Other stimulant dependence with stimulant-induced psychotic disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F15.25 refers to a condition characterized by dependence on stimulants, such as cocaine or methamphetamines, accompanied by psychotic symptoms induced by stimulant use. This diagnosis highlights a complex mental health issue where substance dependency and psychosis occur together, often requiring comprehensive treatment and support. The disorder affects an individual's perception, thoughts, and behaviors, disrupting daily functioning and well-being.
Causes & Symptoms
Clinical Causes: Repeated use of stimulant substances like cocaine, methamphetamine, or other illicit stimulants Genetic predisposition to substance dependence or psychotic disorders Environmental factors, including exposure to stressful or chaotic surroundings History of mental health issues, which may increase vulnerability Prolonged or high-dose use of stimulants leading to neurochemical imbalances
Key Symptoms: Hallucinations, especially visual or auditory, related to stimulant use Delusional thinking or paranoia Rapid mood swings or agitation Confusion or disorganized thinking Increased energy and alertness, often followed by exhaustion Physical symptoms like increased heart rate, high blood pressure, and sweating Loss of interest in daily activities or withdrawal from social interactions Difficulty concentrating or maintaining focus Cravings for stimulants and compulsive drug-seeking behavior Possible violent or aggressive behaviors during psychotic episodes
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough clinical assessment, including interviews about substance use history, mental health status, and symptom presentation. Healthcare professionals may utilize specific criteria from psychiatric manuals to determine the presence of stimulant dependence alongside psychotic features. Laboratory tests, such as urine or blood screenings, can confirm recent stimulant use. Psychological evaluations are also critical in differentiating primary psychotic disorders from stimulant-induced psychosis.
Treatment Protocols: Detoxification and medical management to safely manage withdrawal symptoms Psychosocial interventions like cognitive-behavioral therapy (CBT) to modify harmful behaviors and thoughts Medication-assisted treatment (MAT), such as antipsychotics, to control psychotic symptoms Support groups and counseling to promote recovery and prevent relapse Addressing underlying mental health conditions that may contribute to substance use Long-term follow-up care to monitor progress and prevent recurrence
Clinical Advice & FAQs
Billing Guidance
Is F15.25 a billable ICD-10 code?
Yes, F15.25 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F15.25?
Clinical documentation must specify the nature of Other stimulant dependence with stimulant-induced psychotic disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
